ClinicalTrials.gg

Ischemic Attack, Transient clinical trials

Its pipeline, or its studies — you choose. Free with an account during the beta.

The registry lists 329 studies for Ischemic Attack, Transient across more than 10 countries. 71 are recruiting or about to start. 66 of them are mainly about Ischemic Attack, Transient (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-12.

Status

Completed
170
Recruiting
54
Status unknown
49
Not yet recruiting
16
Terminated
14
Active, not recruiting
14

Phase

Phase 3
37
Phase 2
20
Phase 4
12
Phase 1
6
Early Phase 1
1

Where

United States
88
Canada
47
China
42
Germany
38
France
32
United Kingdom
29

Who develops what

Add Ischemic Attack, Transient to watchlistPro · free during the betaEvery Monday by email · turn it off any time

Every program with a company-led study here in the last two years, whatever its size: 0 programs from 0 companies, 0 with this as their studies’ main aim; 0 with a live phase 3 study; 0 primary completions in the next 12 months.

Comparator & background therapies

What other companies’ phase 2+ studies give as the comparator or the background here (its leading trial sponsor and partners left out): a sign of what new drugs are measured against, not by itself the standard of care, its prescriptions or its market.

DrugLeading trial sponsor · rightsCompanies, last 5 years
AspirinEarlier onlyPhase 4 trial recorded
Evidence
  • NCT03766581 · Bristol-Myers Squibb · Phase 2 · background · “Aspirin” · registered Nov 2018
  • NCT01994720 · AstraZeneca · Phase 3 · comparator · “Acetylsalicylic acid (ASA)” · registered Nov 2013
  • NCT00816166 · codman shurtleff · Phase 3 · comparator · “Aspirin and Clopidogrel (Medical therapy)” · registered Dec 2008
Bayer25% of its industry studies00 studies
ClopidogrelEarlier only
Evidence
  • NCT03766581 · Bristol-Myers Squibb · Phase 2 · background · “Clopidogrel” · registered Nov 2018
  • NCT00816166 · codman shurtleff · Phase 3 · comparator · “Aspirin and Clopidogrel (Medical therapy)” · registered Dec 2008
Sanofi35% of its industry studiesUS: off-patent, 13 generics marketedEU: off-patent, 11 generics authorized00 studies
WarfarinEarlier onlyPhase 4 trial recorded
Evidence
  • NCT00938730 · Astellas Pharma Inc · Phase 2 · comparator · “Warfarin” · registered Jul 2009
  • NCT00129545 · boston scientific · Phase 3 · comparator · “Warfarin” · registered Aug 2005
AstraZeneca15% of its industry studies00 studies

Programs

“Meets, by arms” reads each study’s arms: vs its arm against the therapy’s; + X vs a combination against it; added to it plus the therapy against the therapy; studied with given together only. The next primary completion is the next phase-3 study’s when there is one.

The 0 programs — sign in to see the whole list, free: filter by phase and aim, sort by late development, direct comparisons or the next primary completion.

Primary completion in the next 12 months (0)

Live phase 2 and 3 studies of these programs. Primary completion is when the main measure’s data collection ends, as the registry states it (most are estimates); results come later, if they are announced.

None in the next 12 months.

Read from ClinicalTrials.gov, industry-led studies. Main aim: this is the study’s judged main condition; named, not the main aim: the sponsor names it, the study is about something else; registry mapping only: only the registry’s mapping put it here. Leading trial sponsor is the company leading the most industry studies of a drug, a measure of trial activity, not of rights. US and EU rights, and Approved: from the regulators’ records (FDA’s Drugs@FDA via openFDA; EMA’s medicines data) — the holder of a marketed or authorized original, generics and other companies’ versions; not rights elsewhere, nor approval for this condition. Phase 4 trial recorded, where neither lists it: a phase 4 study exists somewhere. Not read yet: labels by indication, exclusivity, licenses, line of therapy, academic comparators, sales.

What is being tested here

Drugs under test in Ischemic Attack, Transient studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

Drug classes tested here Statins 2 open · P2Y12 inhibitors 1 open · Factor Xa inhibitors 5

Coming up

23studies finish main data collection within a year3 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 54 Ischemic Attack, Transient studies recruiting now, 36 (67%) set no upper age limit and 6 (11%) stop at 75 or younger. 6 (11%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 9 (17%) take healthy volunteers.

Recruiting studies that take each age, of 54
AgeWomenMen
103 (6%)3 (6%)
1840 (74%)40 (74%)
3042 (78%)42 (78%)
4049 (91%)49 (91%)
5050 (93%)50 (93%)
6552 (96%)52 (96%)
7549 (91%)49 (91%)
8542 (78%)42 (78%)

Across all 329 studies, recruiting or not: 8% stop at 75 or younger and 5% at 65; 12% take children; 0% are for women only and 1% for men only; 10% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Ischemic Attack, Transient studies take

Of 13 phase 3 interventional studies under Ischemic Attack, Transient, half reached primary completion within 32 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 332 mo22–51 · 13 studies——
Interventional, no phase46 mo23–72 · 71 studies—48 mo24–72 · 64 studies
Observational49 mo22–92 · 75 studies—52 mo22–101 · 71 studies

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 18, 2026.

Studies

Recruiting first, then most recently updated. Showing 50 of 329. Browse all 329 → or search them.